A Vision for Change: Exploring Biosimilars in Retinal Disease Management

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/04/30/72/043072c4-0983-19bf-c0e7-44ca90024003/mza_13298409977858536834.jpg/600x600bb.jpg

Eye on Ocular Health

ReachMD

55 episodes

1 month ago

Eye on Ocular Health features expert commentary on the management and prevention of debilitating eye problems, such as age-related macular degeneration, diabetic retinopathy, ocular traumas, and chronic dry eye. This series features commentary from renowned ophthalmologists discussing the most successful diagnostic and treatment options emerging in practice.

Science

Medicine

RSS

All content for Eye on Ocular Health is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

A Vision for Change: Exploring Biosimilars in Retinal Disease Management

Eye on Ocular Health

2 years ago

A Vision for Change: Exploring Biosimilars in Retinal Disease Management

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Arghavan Almony, MD

The production of biosimilar therapies is setting the stage for a shift in how we approach treating patients with wet AMD, diabetic retinopathy, macular edema, and other retinal diseases, but many questions remain regarding how their efficacy and safety compare to the reference products and how we can best talk to our patients about these treatment options. To help shed light on these and other FAQs, Dr. Mary Katherine Cheeley speaks with Dr. Arghavan Almony, Adjunct Assistant Professor at Wallace School of Osteopathic Medicine at Campbell University in North Carolina.